» Articles » PMID: 34684014

Exploring Acceptability Drivers of Oral Antibiotics in Children: Findings from an International Observational Study

Abstract

Antibiotics are among the most commonly prescribed drugs in children. Adherence to the treatment with these drugs is of the utmost importance to prevent the emergence of resistant bacteria, a global health threat. In children, medicine acceptability is likely to have a significant impact on compliance. Herein we used a multivariate approach, considering simultaneously the many aspects of acceptability to explore the drivers of oral antibiotic acceptability in children under twelve, especially in toddlers and in preschoolers. Based on 628 real-life observer reports of the intake of 133 distinct medicines, the acceptability reference framework highlighted the influence of many factors such as age and sex of patients, previous exposure to treatment, place of administration, administration device, flavor agent in excipients and active pharmaceutical ingredient. These findings from an international observational study emphasize the multidimensional nature of acceptability. Therefore, it is crucial to consider all these different aspects for assessing this multi-faceted concept and designing or prescribing a medicine in order to reach adequate acceptability in the target population.

Citing Articles

Development of a Hydrocortisone Orodispersible Thin Film Containing Its Succinate Prodrug.

Boisseillier C, Demange-Labriet L, Kariyawasam D, Marchadour P, Fauqueur A, Annereau M Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861149 PMC: 11768698. DOI: 10.3390/ph18010086.


Dosage Forms Suitability in Pediatrics: Acceptability of Antibiotics in a German Hospital.

Klingmann V, Vallet T, Munch J, Wolters L, Stegemann R, Bosse H Antibiotics (Basel). 2023; 12(12).

PMID: 38136743 PMC: 10740640. DOI: 10.3390/antibiotics12121709.


A Guide to Best Practice in Sensory Analysis of Pharmaceutical Formulations.

Clapham D, Belissa E, Inghelbrecht S, Pense-Lheritier A, Ruiz F, Sheehan L Pharmaceutics. 2023; 15(9).

PMID: 37765288 PMC: 10535428. DOI: 10.3390/pharmaceutics15092319.


Paediatric medicine issues and gaps from healthcare workers point of view: survey results and a narrative review from the global accelerator for paediatric formulations project.

Barbieri E, Minotti C, Cavagnis S, Giaquinto C, Cappello B, Penazzato M Front Pharmacol. 2023; 14:1200848.

PMID: 37529704 PMC: 10390094. DOI: 10.3389/fphar.2023.1200848.


Pharmaceutical Oral Formulation of Methionine as a Pediatric Treatment in Inherited Metabolic Disease.

Querin B, Schweitzer-Chaput A, Cisternino S, Auvity S, Fauqueur A, Negbane A Pharmaceutics. 2023; 15(3).

PMID: 36986818 PMC: 10056843. DOI: 10.3390/pharmaceutics15030957.


References
1.
Cervino G, Cicciu M, Biondi A, Bocchieri S, Herford A, Laino L . Antibiotic Prophylaxis on Third Molar Extraction: Systematic Review of Recent Data. Antibiotics (Basel). 2019; 8(2). PMC: 6627726. DOI: 10.3390/antibiotics8020053. View

2.
Dagan R, Shvartzman P, Liss Z . Variation in acceptance of common oral antibiotic suspensions. Pediatr Infect Dis J. 1994; 13(8):686-90. DOI: 10.1097/00006454-199408000-00002. View

3.
Mendelson M, Matsoso M . The World Health Organization Global Action Plan for antimicrobial resistance. S Afr Med J. 2015; 105(5):325. DOI: 10.7196/samj.9644. View

4.
Saito J, Miyamoto S, Yamada M, Yamatani A, Ruiz F, Vallet T . Adherence and Acceptability of an Oral Antibiotic Used for the Prevention of Pediatric Urinary Tract Infection in Japan. Pharmaceutics. 2021; 13(3). PMC: 8000562. DOI: 10.3390/pharmaceutics13030345. View

5.
Cohen R, De La Rocque F, Lecuyer A, Wollner C, Bodin M, Wollner A . Study of the acceptability of antibiotic syrups, suspensions, and oral solutions prescribed to pediatric outpatients. Eur J Pediatr. 2008; 168(7):851-7. DOI: 10.1007/s00431-008-0857-0. View